Table 2 Results to docetaxel plus doxorubicin neoadjuvant chemotherapy
| Response | No. of Pts (%) |
|---|---|
| Histopathologic response | |
| Pathologic complete response | 4 (5.1) |
| Minimal residual disease | 10 (12.8) |
| Gross residual disease | 64 (82.1) |
| Response | No. of Pts (%) |
|---|---|
| Histopathologic response | |
| Pathologic complete response | 4 (5.1) |
| Minimal residual disease | 10 (12.8) |
| Gross residual disease | 64 (82.1) |